Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed, indicating a minor maintenance update to the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedDifference0.3%

- Check50 days agoChange DetectedThe page now displays a revision note indicating the site version was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedPublications section now states entries are automatically filled from PubMed and may not relate to the study, and the revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check64 days agoChange DetectedThe notice about government funding and potential data updates was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedNo significant changes detected on the page; the study title, overview, eligibility criteria, and locations appear unchanged.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.